SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons
Tetanus neurotoxin causes the disease tetanus, which is characterized by rigid paralysis. The toxin acts by inhibiting the release of neurotransmitters from inhibitory neurons in the spinal cord that innervate motor neurons and is unique among the clostridial neurotoxins due to its ability to shuttle from the periphery to the central nervous system. Tetanus neurotoxin is thought to interact with a high affinity receptor complex that is composed of lipid and protein components; however, the identity of the protein receptor remains elusive. In the current study, we demonstrate that toxin binding, to dissociated hippocampal and spinal cord neurons, is greatly enhanced by driving synaptic vesicle exocytosis. Moreover, tetanus neurotoxin entry and subsequent cleavage of synaptobrevin II, the substrate for this toxin, was also dependent on synaptic vesicle recycling. Next, we identified the potential synaptic vesicle binding protein for the toxin and found that it corresponded to SV2; tetanus neurotoxin was unable to cleave synaptobrevin II in SV2 knockout neurons. Toxin entry into knockout neurons was rescued by infecting with viruses that express SV2A or SV2B. Tetanus toxin elicited the hyper excitability in dissociated spinal cord neurons - due to preferential loss of inhibitory transmission - that is characteristic of the disease. Surprisingly, in dissociated cortical cultures, low concentrations of the toxin preferentially acted on excitatory neurons. Further examination of the distribution of SV2A and SV2B in both spinal cord and cortical neurons revealed that SV2B is to a large extent localized to excitatory terminals, while SV2A is localized to inhibitory terminals. Therefore, the distinct effects of tetanus toxin on cortical and spinal cord neurons are not due to differential expression of SV2 isoforms. In summary, the findings reported here indicate that SV2A and SV2B mediate binding and entry of tetanus neurotoxin into central neurons.
Vyšlo v časopise:
SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons. PLoS Pathog 6(11): e32767. doi:10.1371/journal.ppat.1001207
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1001207
Souhrn
Tetanus neurotoxin causes the disease tetanus, which is characterized by rigid paralysis. The toxin acts by inhibiting the release of neurotransmitters from inhibitory neurons in the spinal cord that innervate motor neurons and is unique among the clostridial neurotoxins due to its ability to shuttle from the periphery to the central nervous system. Tetanus neurotoxin is thought to interact with a high affinity receptor complex that is composed of lipid and protein components; however, the identity of the protein receptor remains elusive. In the current study, we demonstrate that toxin binding, to dissociated hippocampal and spinal cord neurons, is greatly enhanced by driving synaptic vesicle exocytosis. Moreover, tetanus neurotoxin entry and subsequent cleavage of synaptobrevin II, the substrate for this toxin, was also dependent on synaptic vesicle recycling. Next, we identified the potential synaptic vesicle binding protein for the toxin and found that it corresponded to SV2; tetanus neurotoxin was unable to cleave synaptobrevin II in SV2 knockout neurons. Toxin entry into knockout neurons was rescued by infecting with viruses that express SV2A or SV2B. Tetanus toxin elicited the hyper excitability in dissociated spinal cord neurons - due to preferential loss of inhibitory transmission - that is characteristic of the disease. Surprisingly, in dissociated cortical cultures, low concentrations of the toxin preferentially acted on excitatory neurons. Further examination of the distribution of SV2A and SV2B in both spinal cord and cortical neurons revealed that SV2B is to a large extent localized to excitatory terminals, while SV2A is localized to inhibitory terminals. Therefore, the distinct effects of tetanus toxin on cortical and spinal cord neurons are not due to differential expression of SV2 isoforms. In summary, the findings reported here indicate that SV2A and SV2B mediate binding and entry of tetanus neurotoxin into central neurons.
Zdroje
1. SchiavoG
MatteoliM
MontecuccoC
2000 Neurotoxins affecting neuroexocytosis. Physiol Rev 80 717 766
2. FaberK
1890 Die Pathogenie des Tetanus. Berl Klin Wochenschr 27 710 717
3. TizzoniG
CattaniG
1890 Untersuchungen uber das Tetanusgift. Zentralbl Bakt 8 69 73
4. MontecuccoC
1995 Clostridial neurotoxins : the molecular pathogenesis of tetanus and botulism Berlin ; New York Springer vii, 278
5. SchiavoG
RossettoO
SantucciA
DasGuptaBR
MontecuccoC
1992 Botulinum neurotoxins are zinc proteins. J Biol Chem 267 23479 23483
6. BlasiJ
ChapmanER
LinkE
BinzT
YamasakiS
1993 Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365 160 163
7. BlasiJ
ChapmanER
YamasakiS
BinzT
NiemannH
1993 Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. Embo J 12 4821 4828
8. SchiavoG
MalizioC
TrimbleWS
Polverino de LauretoP
MilanG
1994 Botulinum G neurotoxin cleaves VAMP/synaptobrevin at a single Ala-Ala peptide bond. J Biol Chem 269 20213 20216
9. SchiavoG
SantucciA
DasguptaBR
MehtaPP
JontesJ
1993 Botulinum neurotoxins serotypes A and E cleave SNAP-25 at distinct COOH-terminal peptide bonds. FEBS Lett 335 99 103
10. SchiavoG
BenfenatiF
PoulainB
RossettoO
Polverino de LauretoP
1992 Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin. Nature 359 832 835
11. SudhofTC
RothmanJE
2009 Membrane fusion: grappling with SNARE and SM proteins. Science 323 474 477
12. ChapmanER
2002 Synaptotagmin: a Ca(2+) sensor that triggers exocytosis? Nat Rev Mol Cell Biol 3 498 508
13. SmithLDS
SugiyamaH
1988 Botulism : the organism, its toxins, the disease Springfield, Ill., USA Thomas xi, 171
14. HerrerosJ
NgT
SchiavoG
2001 Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons. Mol Biol Cell 12 2947 2960
15. LalliG
BohnertS
DeinhardtK
VerasteguiC
SchiavoG
2003 The journey of tetanus and botulinum neurotoxins in neurons. Trends Microbiol 11 431 437
16. BohnertS
SchiavoG
2005 Tetanus toxin is transported in a novel neuronal compartment characterized by a specialized pH regulation. J Biol Chem 280 42336 42344
17. DeinhardtK
SalinasS
VerasteguiC
WatsonR
WorthD
2006 Rab5 and Rab7 Control Endocytic Sorting along the Axonal Retrograde Transport Pathway. Neuron 52 293 305
18. SchwabME
SudaK
ThoenenH
1979 Selective retrograde transsynaptic transfer of a protein, tetanus toxin, subsequent to its retrograde axonal transport. J Cell Biol 82 798 810
19. CurtisDR
De GroatWC
1968 Tetanus toxin and spinal inhibition. Brain Res 10 208 212
20. MontecuccoC
1986 How do tetanus and botulinum toxins bind to neuronal membranes? Trends in Biochemical Sciences 11 314 317
21. KitamuraM
TakamiyaK
AizawaS
FurukawaK
FurukawaK
1999 Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice. Biochim Biophys Acta 1441 1 3
22. KitamuraM
IgimiS
FurukawaK
FurukawaK
2005 Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxins. Biochim Biophys Acta 1741 1 3
23. PierceEJ
DavisonMD
PartonRG
HabigWH
CritchleyDR
1986 Characterization of tetanus toxin binding to rat brain membranes. Evidence for a high-affinity proteinase-sensitive receptor. Biochem J 236 845 852
24. PartonRG
OcklefordCD
CritchleyDR
1988 Tetanus toxin binding to mouse spinal cord cells: an evaluation of the role of gangliosides in toxin internalization. Brain Res 475 118 127
25. YavinE
NathanA
1986 Tetanus toxin receptors on nerve cells contain a trypsin-sensitive component. Eur J Biochem 154 403 407
26. DeinhardtK
SchiavoG
2005 Endocytosis and retrograde axonal traffic in motor neurons. Biochem Soc Symp 139 150
27. DongM
YehF
TeppWH
DeanC
JohnsonEA
2006 SV2 is the protein receptor for botulinum neurotoxin A. Science 312 592 596
28. DongM
TeppWH
LiuH
JohnsonEA
ChapmanER
2007 Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J Cell Biol 179 1511 1522
29. DongM
RichardsDA
GoodnoughMC
TeppWH
JohnsonEA
2003 Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol 162 1293 1303
30. DongM
LiuH
TeppWH
JohnsonEA
JanzR
2008 Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol Biol Cell 19 5226 5237
31. NishikiT
KamataY
NemotoY
OmoriA
ItoT
1994 Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem 269 10498 10503
32. MahrholdS
RummelA
BigalkeH
DavletovB
BinzT
2006 The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves. FEBS Lett 580 2011 2014
33. RummelA
KarnathT
HenkeT
BigalkeH
BinzT
2004 Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J Biol Chem 279 30865 30870
34. MatteoliM
VerderioC
RossettoO
IezziN
CocoS
1996 Synaptic vesicle endocytosis mediates the entry of tetanus neurotoxin into hippocampal neurons. Proc Natl Acad Sci U S A 93 13310 13315
35. MunroP
KojimaH
DupontJL
BossuJL
PoulainB
2001 High sensitivity of mouse neuronal cells to tetanus toxin requires a GPI-anchored protein. Biochem Biophys Res Commun 289 623 629
36. PartonRG
OcklefordCD
CritchleyDR
1987 A study of the mechanism of internalisation of tetanus toxin by primary mouse spinal cord cultures. J Neurochem 49 1057 1068
37. HerrerosJ
LalliG
MontecuccoC
SchiavoG
2000 Tetanus toxin fragment C binds to a protein present in neuronal cell lines and motoneurons. J Neurochem 74 1941 1950
38. GreeneCE
2006 Infectious diseases of the dog and cat St. Louis, Mo. Saunders Elsevier xxix, 1387
39. SchumakerHB
LamontA
FirorWM
1939 The reaction of “tetanus sensitive” and “tetanus resistant” animals to the injection of tetanal toxin into the spinal cord. J Immunol 37 425 433
40. BoxM
ParksDA
KnightA
HaleC
FishmanPS
2003 A multi-domain protein system based on the HC fragment of tetanus toxin for targeting DNA to neuronal cells. J Drug Target 11 333 343
41. TakamoriS
HoltM
SteniusK
LemkeEA
GronborgM
2006 Molecular anatomy of a trafficking organelle. Cell 127 831 846
42. LalliG
HerrerosJ
OsborneSL
MontecuccoC
RossettoO
1999 Functional characterisation of tetanus and botulinum neurotoxins binding domains. J Cell Sci 112 Pt 16 2715 2724
43. BaldwinMR
BarbieriJT
2007 Association of botulinum neurotoxin serotypes a and B with synaptic vesicle protein complexes. Biochemistry 46 3200 3210
44. BizziniB
StoeckelK
SchwabM
1977 An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems. J Neurochem 28 529 542
45. DumasM
SchwabME
BaumannR
ThoenenH
1979 Retrograde transport of tetanus toxin through a chain of two neurons. Brain Res 165 354 357
46. MorrisNP
ConsiglioE
KohnLD
HabigWH
HardegreeMC
1980 Interaction of fragments B and C of tetanus toxin with neural and thyroid membranes and with gangliosides. J Biol Chem 255 6071 6076
47. WellerU
TaylorCF
HabermannE
1986 Quantitative comparison between tetanus toxin, some fragments and toxoid for binding and axonal transport in the rat. Toxicon 24 1055 1063
48. van der BliekAM
RedelmeierTE
DamkeH
TisdaleEJ
MeyerowitzEM
1993 Mutations in human dynamin block an intermediate stage in coated vesicle formation. J Cell Biol 122 553 563
49. SimpsonLL
1984 The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin. J Pharmacol Exp Ther 229 182 187
50. RummelA
HafnerK
MahrholdS
DarashchonakN
HoltM
2009 Botulinum neurotoxins C, E and F bind gangliosides via a conserved binding site prior to stimulation-dependent uptake with botulinum neurotoxin F utilising the three isoforms of SV2 as second receptor. J Neurochem 110 1942 1954
51. CrowderKM
GuntherJM
JonesTA
HaleBD
ZhangHZ
1999 Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci U S A 96 15268 15273
52. JanzR
GodaY
GeppertM
MisslerM
SudhofTC
1999 SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron 24 1003 1016
53. ScrantonTW
IwataM
CarlsonSS
1993 The SV2 protein of synaptic vesicles is a keratan sulfate proteoglycan. J Neurochem 61 29 44
54. JanzR
SudhofTC
1999 SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. Neuroscience 94 1279 1290
55. FeanyMB
LeeS
EdwardsRH
BuckleyKM
1992 The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell 70 861 867
56. BuckleyK
KellyRB
1985 Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J Cell Biol 100 1284 1294
57. BajjaliehSM
PetersonK
ShinghalR
SchellerRH
1992 SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science 257 1271 1273
58. FuZ
ChenC
BarbieriJT
KimJJ
BaldwinMR
2009 Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F. Biochemistry 48 5631 5641
59. DeinhardtK
BerninghausenO
WillisonHJ
HopkinsCR
SchiavoG
2006 Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1. J Cell Biol 174 459 471
60. RouxS
ColasanteC
Saint ClomentC
BarbierJ
CurieT
2005 Internalization of a GFP-tetanus toxin C-terminal fragment fusion protein at mature mouse neuromuscular junctions. Mol Cell Neurosci 30 572 582
61. MatsudaM
SugimotoN
OzutsumiK
HiraiT
1982 Acute botulinum-like intoxication by tetanus neurotoxin in mice. Biochem Biophys Res Commun 104 799 805
62. NicholsBJ
2003 GM1-containing lipid rafts are depleted within clathrin-coated pits. Curr Biol 13 686 690
63. EvansDM
WilliamsRS
ShoneCC
HambletonP
MellingJ
1986 Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Eur J Biochem 154 409 416
64. SchmidtJJ
SiegelLS
1986 Purification of type E botulinum neurotoxin by high-performance ion exchange chromatography. Anal Biochem 156 213 219
65. ChenC
FuZ
KimJJ
BarbieriJT
BaldwinMR
2009 Gangliosides as high affinity receptors for tetanus neurotoxin. J Biol Chem 284 26569 26577
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2010 Číslo 11
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Zn Inhibits Coronavirus and Arterivirus RNA Polymerase Activity and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
- The Female Lower Genital Tract Is a Privileged Compartment with IL-10 Producing Dendritic Cells and Poor Th1 Immunity following Infection
- Crystal Structure and Size-Dependent Neutralization Properties of HK20, a Human Monoclonal Antibody Binding to the Highly Conserved Heptad Repeat 1 of gp41
- The Arabidopsis Resistance-Like Gene Is Activated by Mutations in and Contributes to Resistance to the Bacterial Effector AvrRps4